Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9585357rdf:typepubmed:Citationlld:pubmed
pubmed-article:9585357lifeskim:mentionsumls-concept:C2926606lld:lifeskim
pubmed-article:9585357lifeskim:mentionsumls-concept:C0206193lld:lifeskim
pubmed-article:9585357lifeskim:mentionsumls-concept:C0149615lld:lifeskim
pubmed-article:9585357lifeskim:mentionsumls-concept:C0205494lld:lifeskim
pubmed-article:9585357lifeskim:mentionsumls-concept:C2607943lld:lifeskim
pubmed-article:9585357pubmed:issue5lld:pubmed
pubmed-article:9585357pubmed:dateCreated1998-5-21lld:pubmed
pubmed-article:9585357pubmed:abstractTextThe aim of this study was to assess neurological, neuropsychological, and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation (BMT) who were recruited from a hematological outpatient clinic. In addition, risk factors for the development of late neurological complications were identified. In contrast to previous studies on autopsied patients, our study design provoked a bias away from increased neurological sequelae, because patients with early complications after BMT were excluded. Fifty-nine allogeneic patients and 7 autologous BMT patients underwent clinical examination, short neuropsychological testing, and cranial magnetic resonance imaging (MRI) 34 +/- 26 months after BMT. The pathological results of the neurological examination (abnormal 64%) and the MRI examination (white matter lesions, 54%; atrophy, 11%) were associated with the occurrence of chronic graft-versus-host disease (GvHD) evolving from acute GvHD, with corticosteroid therapy and with cyclosporine medication. Neuropsychological impairment (cognitive deficits, 37%) was associated with long-term cyclosporine medication and age. No influence of pre-BMT disease, BMT donor status, or the conditioning regimen was found. These results suggest that the frequent neurological abnormalities in long-term survivors of allogeneic BMT are associated with chronic GvHD and with the resulting immunosuppression as major risk factors.lld:pubmed
pubmed-article:9585357pubmed:languageenglld:pubmed
pubmed-article:9585357pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9585357pubmed:citationSubsetIMlld:pubmed
pubmed-article:9585357pubmed:statusMEDLINElld:pubmed
pubmed-article:9585357pubmed:monthMaylld:pubmed
pubmed-article:9585357pubmed:issn0364-5134lld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:KolbH JHJlld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:HollerEElld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:SchleuningMMlld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:StraubeAAlld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:PadovanC SCSlld:pubmed
pubmed-article:9585357pubmed:authorpubmed-author:YousryT ATAlld:pubmed
pubmed-article:9585357pubmed:issnTypePrintlld:pubmed
pubmed-article:9585357pubmed:volume43lld:pubmed
pubmed-article:9585357pubmed:ownerNLMlld:pubmed
pubmed-article:9585357pubmed:authorsCompleteYlld:pubmed
pubmed-article:9585357pubmed:pagination627-33lld:pubmed
pubmed-article:9585357pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:meshHeadingpubmed-meshheading:9585357-...lld:pubmed
pubmed-article:9585357pubmed:year1998lld:pubmed
pubmed-article:9585357pubmed:articleTitleNeurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation.lld:pubmed
pubmed-article:9585357pubmed:affiliationDepartment of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.lld:pubmed
pubmed-article:9585357pubmed:publicationTypeJournal Articlelld:pubmed